DOW JONES23,719.37+285.80 1.22%
S&P 5002,789.82+39.84 1.45%
NASDAQ8,153.58+62.67 0.77%

Morgan Stanley Maintains Overweight on Amgen, Lowers Price Target to $277

Morgan Stanley maintains Amgen (NASDAQ:AMGN) with a Overweight and lowers the price target from $280 to $277.

Benzinga · 01/17/2020 13:17

Morgan Stanley maintains Amgen (NASDAQ:AMGN) with a Overweight and lowers the price target from $280 to $277.